Market closedNon-fractional
PetMed Express/PETS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About PetMed Express
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
Ticker
PETS
Sector
Consumer Cyclicals
Trading on
NASDAQ
Industry
Specialty Retail
Headquarters
Delray Beach, United States
Employees
287
Website
www.1800petmeds.com
PetMed Express Metrics
BasicAdvanced
$77M
Market cap
-
P/E ratio
-$0.37
EPS
0.69
Beta
$0.60
Dividend rate
15.50%
Dividend yield
Price and volume
Market cap
$77M
Beta
0.69
Dividend rate
$0.60
Financial strength
Current ratio
1.298
Quick ratio
0.812
Long term debt to equity
1.029
Total debt to equity
1.503
Management effectiveness
Return on assets (TTM)
-3.02%
Return on equity (TTM)
-7.22%
Valuation
Price to revenue (TTM)
0.281
Price to book
0.81
Price to tangible book (TTM)
1.47
Price to free cash flow (TTM)
-406.897
Dividend yield (TTM)
15.50%
Growth
Revenue change (TTM)
9.54%
Earnings per share change (TTM)
-248.00%
3-year revenue growth
-2.54%
3-year earnings per share growth
-32.25%
3-year dividend per share growth
-18.78%
What the Analysts think about PetMed Express
Analyst Ratings
Majority rating from 2 analysts.
PetMed Express Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$65M
-56.23%
Net income
-$2M
400.00%
Profit margin
-3.06%
1,076.92%
PetMed Express Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
-$0.25
-$0.04
-
-$0.10
-
Expected
$0.14
$0.07
-$0.01
-$0.01
-$0.07
Surprise
-282.93%
-154.55%
-
900.00%
-
PetMed Express News
AllArticlesVideos
PetMed Express, Inc. Investors: Company Investigated by the Portnoy Law Firm
GlobeNewsWire·2 weeks ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
Accesswire·3 weeks ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for PetMed Express stock?
PetMed Express (PETS) has a market cap of $77M as of July 06, 2024.
What is the P/E ratio for PetMed Express stock?
The price to earnings (P/E) ratio for PetMed Express (PETS) stock is 0 as of July 06, 2024.
Does PetMed Express stock pay dividends?
Yes, the PetMed Express (PETS) stock pays dividends to shareholders. As of July 06, 2024, the dividend rate is $0.6 and the yield is 15.5%. PetMed Express has a payout ratio of 0% on a trailing twelve-month basis.
When is the next PetMed Express dividend payment date?
The next PetMed Express (PETS) dividend payment date is unconfirmed.
What is the beta indicator for PetMed Express?
PetMed Express (PETS) has a beta rating of 0.69. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell PetMed Express stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.